Botox therapeutic and Botox Cosmetic contain the exact same active ingredient, onabotulinumtoxinA, in the same formulation with the same inactive ingredients (human albumin and sodium chloride). Neither product comes from the manufacturer at a higher concentration than the other. The difference in concentration happens after the vial is opened, when the provider mixes it with saline before injection.
Same Powder, Different Labels
Both products are made by AbbVie and start as identical freeze-dried powders. Botox Cosmetic is available in 50-unit and 100-unit vials. Therapeutic Botox is available in those sizes plus a 200-unit vial, which exists because therapeutic treatments require much larger doses. But unit for unit, the powder in every vial is the same drug.
The “Cosmetic” label is a regulatory and marketing distinction. The FDA approved each product under separate labeling so that cosmetic uses (like frown lines) and medical uses (like chronic migraine or muscle spasticity) have their own set of approved indications, dosing guidelines, and billing codes. The FDA itself notes that adverse events seen with one have the potential to occur with the other, precisely because the formulations are identical.
Why Therapeutic Injections Often Use a Higher Concentration
The real difference shows up in how the provider reconstitutes the powder. Before injection, saline is added to the vial to dissolve the powder into a liquid. The amount of saline determines how concentrated the final solution is, and the standard ratios differ between cosmetic and therapeutic uses.
For cosmetic treatments like frown lines, the standard is 2.5 mL of saline added to a 100-unit vial. That yields a concentration of 4 units per 0.1 mL. For therapeutic uses like chronic migraine or limb spasticity, the recommended dilution is 2 mL of saline per 100 units, producing 5 units per 0.1 mL. So yes, the therapeutic solution is typically mixed about 25% more concentrated than the cosmetic solution.
This isn’t because the product itself is different. It’s a deliberate choice by the prescribing guidelines, and the provider could technically adjust the ratio for either application.
Why Concentration Matters
The concentration of the reconstituted solution affects how far the toxin spreads from the injection site. A more concentrated solution (less saline) tends to stay closer to where it’s injected, while a more diluted solution diffuses more broadly through surrounding tissue. This diffusion profile has real clinical consequences.
For cosmetic work, you generally want a moderate concentration that covers a specific facial muscle without drifting into neighboring muscles, which could cause unwanted effects like a drooping eyelid. For large therapeutic targets like the calf muscles in leg spasticity, providers sometimes use a slightly more dilute solution on purpose to spread the effect across a bigger muscle. In other therapeutic cases, a higher concentration keeps the toxin tightly focused on the target.
Factors beyond concentration also influence spread: needle size, injection speed, and the volume injected at each site all play a role. Larger needles and faster injections can cause more tissue disruption, which pushes the toxin further from its intended target.
Dosage Is the Bigger Difference
Concentration aside, the most dramatic difference between cosmetic and therapeutic Botox is simply how many units are used. A standard cosmetic treatment for frown lines involves 20 units total, split across five injection sites with 4 units each. Compare that to chronic migraine treatment, which calls for 155 units spread across 31 injection sites in the head and neck. Treating lower limb spasticity in adults can require 300 to 400 units divided among five leg muscles.
This is also why the 200-unit vial exists exclusively in the therapeutic line. Cosmetic treatments rarely need more than 50 to 100 units in a single session, while a patient being treated for spasticity might need multiple vials.
Billing and Insurance Implications
Because the two products carry separate FDA approvals and separate billing codes, they aren’t interchangeable from an insurance perspective. A provider treating chronic migraine needs to use and bill for “Botox” (the therapeutic label), not “Botox Cosmetic,” even though the vials contain the same substance. Insurance companies will typically only cover the therapeutic version for approved medical conditions. Cosmetic treatments are almost always paid out of pocket.
This distinction also means that a cosmetic practice buying Botox Cosmetic vials and a neurology clinic buying therapeutic Botox vials are purchasing the same molecule at potentially different price points, through different supply channels, with different labeling on the box.